MA H2203Introducedas of 2025-02-27
Establishing a pilot program for access to regulated psilocybin
Plain-English summary
What happened: A Massachusetts bill establishing a regulated psilocybin access pilot program has passed committee and been referred to the House Ways and Means Committee for fiscal review.
Why it matters: Advancement through Ways and Means indicates the bill is under active consideration, which could create a near-term regulated framework affecting cultivators, service centers, and patients.
Affects: cultivators and retailers and patients
LATEST ACTION: Committee recommended bill ought to pass and referred to the committee on House Ways and Means
READ THE FULL BILL TEXT →Follow Massachusetts cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore Massachusetts cannabis bills
H5403REPORT of the SPECIAL JOINT COMMITTEE on INITIATIVE PETITIONS on the INITIATIVE PETITION of ANGIE AN-CHI TSO
AND OTHERS FOR THE PASSAGE OF AN ACT TO RESTORE A SENSIBLE MARIJUANA POLICY (see House, No. 5002).IntroducedH5350Modernizing the commonwealth’s cannabis lawsPassedS2985Order relative to authorizing the joint committee on Cannabis Policy to make an investigation and study of certain current Senate documents relative to enable private donations to the cannabis social equity trust fund.IntroducedH5002To restore a sensible marijuana policyIntroducedH4986Relative to therapeutic psilocybin treatment centersIntroducedS2800Regulating the sale of hemp products to protect public healthIntroducedS2889Order relative to authorizing the joint committee on Cannabis Policy to make an investigation and study of a certain current Senate document relative to host community agreements.IntroducedS2816Order relative to authorizing the joint committee on Cannabis Policy, to make an investigation and study of certain current Senate documents relative to insurance and treatment matters.Introduced
ALL MASSACHUSETTSCANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.